Evidence map›Paper›PMID 35440001›Full record

ArticleBMC veterinary research2022

β-defensin 118 attenuates inflammation and injury of intestinal epithelial cells upon enterotoxigenic Escherichia coli challenge.

Qingqing Fu, Qian Lin, Daiwen Chen, Bing Yu, Yuheng Luo, Ping Zheng, Xiangbing Mao, Zhiqing Huang, Jie Yu, Junqiu Luo and 2 more

Open access · goldAbstract read
In one paragraph

Article in BMC veterinary research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.3field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Effects of Luteolin in an In Vitro Model of Porcine Intestinal Infections.Animals : an open access journal from MDPI · 2024
    Article
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Qingqing FuInstitute of Animal Nutrition, Sichuan Agricultural University, Chengdu, Sichuan Province, 611130, P. R. China.
Qian LinInstitute of Animal Nutrition, Sichuan Agricultural University, Chengdu, Sichuan Province, 611130, P. R. China.
Daiwen ChenInstitute of Animal Nutrition, Sichuan Agricultural University, Chengdu, Sichuan Province, 611130, P. R. China.
Bing YuInstitute of Animal Nutrition, Sichuan Agricultural University, Chengdu, Sichuan Province, 611130, P. R. China.
Yuheng LuoInstitute of Animal Nutrition, Sichuan Agricultural University, Chengdu, Sichuan Province, 611130, P. R. China.
Ping ZhengInstitute of Animal Nutrition, Sichuan Agricultural University, Chengdu, Sichuan Province, 611130, P. R. China.
Xiangbing MaoInstitute of Animal Nutrition, Sichuan Agricultural University, Chengdu, Sichuan Province, 611130, P. R. China.
Zhiqing HuangInstitute of Animal Nutrition, Sichuan Agricultural University, Chengdu, Sichuan Province, 611130, P. R. China.
Jie YuInstitute of Animal Nutrition, Sichuan Agricultural University, Chengdu, Sichuan Province, 611130, P. R. China.
Junqiu LuoInstitute of Animal Nutrition, Sichuan Agricultural University, Chengdu, Sichuan Province, 611130, P. R. China.
Hui YanInstitute of Animal Nutrition, Sichuan Agricultural University, Chengdu, Sichuan Province, 611130, P. R. China.
Jun HeInstitute of Animal Nutrition, Sichuan Agricultural University, Chengdu, Sichuan Province, 611130, P. R. China. hejun8067@163.com.
Sichuan Agricultural University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAntimicrobial peptides including various defensins have been attracting considerable research interest worldwide, as they have potential to substitute for antibiotics. Moreover, AMPs also have immunomodulatory activity. In this study, we explored the role and its potential mechanisms of β-defensin 118 (DEFB118) in alleviating inflammation and injury of IPEC-J2 cells (porcine jejunum epithelial cell line) upon the enterotoxigenic Escherichia coli (ETEC) challenge.

resultsThe porcine jejunum epithelial cell line (IPEC-J2) pretreated with or without DEFB118 (25 μg/mL) were challenged by ETEC (1×10

conclusionsDEFB118 can alleviate ETEC-induced inflammation in IPEC-J2 cells through inhibition of the NF-κB signaling pathway, resulting in reduced secretion of inflammatory cytokines and decreased cell apoptosis. Therefore, DEFB118 can act as a novel anti-inflammatory agent.

Indexed as

beta-DefensinsEnterotoxigenic Escherichia coliEscherichia coli InfectionsInflammationSwine DiseasesAnimalsCytokinesEpithelial CellsIntestinal MucosaNF-kappa BSwinebeta-DefensinsCytokinesNF-kappa BAntimicrobial peptideETECinflammationIPEC-J2 cellsNF-κB

Identifiers

PMID35440001
PMCPMC9017018
OpenAlexW4224303683

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.